Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 4339 for “"Antagonist"”.
-
EVALUATION OF HUMAN PROLACTIN, ITS ANTAGONIST, AND ANTAGONIST-BASED FUSION PROTEINS AS CHEMOPREVENTATIVE AND THERAPEUTIC AGENTS
… Previously, fusion proteins composed of a PRLR antagonist (G129R) and anti-tumor domains were developed; these included fusions with an angiogenesis inhibitor (Endostatin), an immune system modulator (interleukin-2), and a cytotoxin (PE38KDEL). The rationale was that each fusion protein would …
-
Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a
Nutlin-3a is an MDM2-p53 interaction antagonist that is under investigation in preclinical models for a variety of pediatric malignancies, including neuroblastoma, retinoblastoma, leukemia, and rhabdomyosarcoma. In the current research, we conducted preclinical pharmacology studies of nutlin-3a to …
-
SYNTHESIS OF SELECTIVE C-TYPE LECTIN ANTAGONIST GLYCOMIMETICS
In this thesis we have tackled the problem of identifying high-affinity, selective CLR ligands with two different approaches: in the first approach, we synthesized a diversity library and screened it in microarray format against a group of human CLRs; in the second approach we proceeded to the …
-
IAP antagonist Grim mediates cell death through divergent pathways
… or enhanced by the accumulation of “IAP antagonists”, which promote cell death by utilizing their N-terminal IAP binding motifs (IBMs) to interact with IAPs, to displace caspases from IAP-binding, and to promote IAPs autoubiquitination. Herein, we demonstrate that a Drosophila IAP …
-
Characteristics of iodinated beta-adrenoceptor antagonist ligands in brain.
… interactions of radiolabelled beta-adrenoceptor antagonists with membranes from cerebral tissue of the rat using ligand binding methods. <br></br><br></br> Using tritiated ligands and displacement of the binding with selective beta-adrenoceptor agents (distinguishing between <i>β</i><sub>1</sub>- …
-
Design, Synthesis and Biological Evaluation of Novel Cannabinoid Antagonist
… diaryl group revealed in the prototypical antagonist/inverse agonist SR141716 (Rimonabant) that was presumed to interact with a unique region in the CB1 receptors. Based on our preliminary results we identified a novel series of 1,2,3-triazole ester and keto derivatives as lead compounds …
-
Molecular evolution of a C5aR antagonist against inflammatory disease
New anti-inflammatory drugs with fewer adverse effects than existing drugs may prove to be useful in the treatment of several inflammatory disorders. A critical step in acute inflammation is the infiltration of neutrophils into tissues. Therefore, molecules that target and inhibit this early …
-
Wear behavior of zirconia substrates against different antagonist materials
… distinct surface roughness against different antagonist materials.<br><br>Method: Hemisphere-shaped specimens (diameter of 5mm) constructed from different materials (VM9, Vintage ZR, IPS e.max Press and human enamel) were used as antagonists against plates of two zirconia materials (P-NANOZR, …
-
Cyclization and Derivatization of the Potasium Channel Antagonist Tertiapin
The potent potassium channel antagonist tertiapin-Q was used in order to expand the application of data previously published by Clark et al. and also to further examine the usefulness of a newly published peptide backbone cyclization technique. This peptide was also used in order to investigate the …
-
MMTV encodes a protein antagonist of multiple Apobec family members
… MMTV infection [179], yet no known MMTV-encoded antagonist of mA3 has been identified. MMTV requires replication through B and T lymphocytes [33, 34, 37], both of which express Apobec family proteins, prior to mammary gland infection and tumorigenesis [93, 97]. Experiments were performed to …
-
Deactivation of the LPS antagonist eritoran by HDL-associated apolipoproteins
… a synthetic lipid A analogue that is a powerful antagonist of LPS, however it undergoes a time-dependent deactivation after administration as a consequence of binding to high-density lipoproteins (HDL). At present, there remains much uncertainty surrounding the site of eritoran association with …
-
Identification and in vivo Characterization of a Potential TAAR1 Antagonist
… selective agonists for TAAR1, only one TAAR1 antagonist has been described thus far. We used an in silico screen on a TAAR1 homology model and identified several novel agonists and potential antagonists for TAAR1. One of the identified antagonists (compound 22) was predicted to have favourable …
Page 1 of 217